If you receive a denial letter from your insurer, seek legal advice before appealing the decision, says a leading disability ...
LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...
Cybin Inc., now operating as Helus Pharma, has rebranded and moved its U.S. listing from NYSE American to Nasdaq under the ...
Health Digest on MSN
Reese Witherspoon Took An Outside-The-Box Approach To Dealing With Her Anxiety
The actor has been open about the technique she employs to help with her mental health -- but with regard to whether or not ...
Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserve ...
The year 2025 was a defining one for Incannex,” stated Joel Latham, Incannex Healthcare Chief Executive Officer. “We delivered two independent, positive Phase 2 clinical readouts across distinct CNS ...
San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...
Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.
Neurofeedback treatments are aimed at assisting those struggling with ADHD, generalized anxiety, depression, post-traumatic ...
The global Central Nervous System (CNS) therapeutic market is projected to reach US$ 235.87 billion by 2033. This growth is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback